Supplemental material
Cancer Biology & Therapy
Volume 20, 2019 - Issue 6
Research Paper
Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
Joanna Moes-Sosnowskaa Department of Immunology, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, PolandCorrespondence[email protected]
https://orcid.org/0000-0003-1706-8290View further author information
https://orcid.org/0000-0003-1706-8290View further author information, Iwona K. Rzepeckab Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Polandhttps://orcid.org/0000-0001-7305-6687View further author information
https://orcid.org/0000-0001-7305-6687View further author information, , Agnieszka Dansonka-Mieszkowskab Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Polandhttps://orcid.org/0000-0002-2482-6523View further author information
https://orcid.org/0000-0002-2482-6523View further author information, Lukasz M. Szafrona Department of Immunology, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Polandhttps://orcid.org/0000-0003-1670-0274View further author information
https://orcid.org/0000-0003-1670-0274View further author information, Aneta Balabasd Department of Genetics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Polandhttps://orcid.org/0000-0001-6078-9232View further author information
https://orcid.org/0000-0001-6078-9232View further author information, , & Jolanta Kupryjanczykb Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie Institute – Oncology Center, Warsaw, Polandhttps://orcid.org/0000-0001-5820-0214View further author information
https://orcid.org/0000-0001-5820-0214View further author information show all